AtriCure, Inc. (ATRC) shareholders
Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 7,837,484 | 15.40% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (8.00%), Wellington Investment Advisors Holdings LLP (8.00%) and 1 more | 3,969,269 | 8.00% | 13G (passive) | Jun 30, 2025 |
| Vanguard Portfolio Management | 3,676,303 | 7.22% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Investment Advisors Holdings LLP Joint filing with Wellington Management Group LLP (6.80%), Wellington Group Holdings LLP (6.80%) and 1 more | 3,382,555 | 6.80% | 13G (passive) amendment | Mar 31, 2026 |
| Hood River Capital Management LLC | 3,096,611 | 6.23% | 13G (passive) amendment | Dec 31, 2025 |
| AllianceBernstein L.P. | 2,768,365 | 5.50% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Capital Management | 2,532,965 | 5.08% | 13G (passive) | Mar 31, 2026 |
| Macquarie Management Holdings Inc Joint filing with Macquarie Group Limited (5.06%), Macquarie Investment Management Business Trust (5.06%) | 2,503,205 | 5.06% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ATRC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,474,548 | 8.80% | $125.20M | +431,867 | 0.00% |
| Wellington Management Group Llp | 3,495,603 | 6.87% | $97.81M | +113,048 | 0.02% |
| Vanguard Portfolio Management LLC | 3,127,195 | 6.15% | $87.50M | +424,563 | 0.00% |
| Hood River Capital Management LLC | 2,905,299 | 5.71% | $81.29M | −212,246 | 0.59% |
| Alliancebernstein L.P. | 2,768,365 | 5.44% | $78.98M | −490,507 | 0.03% |
| Vanguard Capital Management LLC | 2,190,413 | 4.31% | $61.29M | +34,649 | 0.00% |
| Nomura Asset Management International Inc. | 1,734,279 | 3.41% | $48.53M | −70,648 | 0.07% |
| Goldman Sachs Group Inc | 1,597,988 | 3.14% | $44.71M | −69,178 | 0.00% |
| State Street Corp | 1,389,989 | 2.73% | $38.94M | +87,827 | 0.00% |
| Marshall Wace, Llp | 1,333,904 | 2.62% | $37.32M | −133,620 | 0.03% |
| Geode Capital Management, LLC | 1,319,687 | 2.59% | $36.93M | +93,571 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 1,296,209 | 2.55% | $36.27M | +1,018,527 | 0.02% |
| Dimensional Fund Advisors LP | 1,044,034 | 2.05% | $29.22M | +46,275 | 0.01% |
| GW&K Investment Management, LLC | 949,516 | 1.87% | $26.57M | −13,899 | 0.21% |
| Neuberger Berman Group LLC | 947,982 | 1.86% | $26.58M | −102,300 | 0.02% |
| Champlain Investment Partners, LLC | 938,567 | 1.85% | $26.26M | −32,544 | 0.67% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 897,419 | 1.76% | $25.11M | −163,387 | 0.03% |
| Bank Of America Corp /De/ | 874,370 | 1.72% | $24.46M | +105,809 | 0.00% |
| Kennedy Capital Management LLC | 857,787 | 1.69% | $24.00M | +23,632 | 0.42% |
| Divisadero Street Capital Management, LP | 800,931 | 1.57% | $22.41M | −359,024 | 0.51% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 252 | 53M | 100.0% | 53 / 102 | 61 / 22 | 7M | 5M |
| Q1 2026 | 224 | 50M | 98.3% | 35 / 83 | 66 / 41 | 11M | 5M |
| Q4 2025 | 234 | 49M | 95.9% | 36 / 91 | 74 / 21 | 6M | 6M |
| Q3 2025 | 223 | 48M | 95.1% | 34 / 70 | 82 / 11 | 3M | 4M |
| Q2 2025 | 201 | 49M | 96.3% | 17 / 78 | 72 / 35 | 6M | 7M |
| Q1 2025 | 221 | 50M | 99.1% | 38 / 77 | 64 / 28 | 8M | 3M |
| Q4 2024 | 213 | 47M | 91.5% | 39 / 69 | 73 / 23 | 3M | 6M |
| Q3 2024 | 202 | 50M | 97.6% | 40 / 58 | 79 / 34 | 10M | 6M |
| Q2 2024 | 198 | 51M | 100.0% | 26 / 102 | 52 / 51 | 9M | 9M |
| Q1 2024 | 224 | 52M | 100.0% | 33 / 84 | 81 / 40 | 10M | 6M |
| Q4 2023 | 233 | 48M | 94.4% | 40 / 102 | 70 / 33 | 6M | 3M |
| Q3 2023 | 230 | 45M | 89.2% | 29 / 93 | 79 / 20 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
248 funds held ATRC in Q2 2026, 37% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ATRC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Hood River Small-Cap Growth Fund | 1,527,073 | 3.00% | $42.73M | 0.64% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,519,312 | 2.99% | $42.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,296,745 | 2.55% | $36.28M | 0.04% | Jun 30, 2026 |
| Nomura Small Cap Core Fund | 1,219,526 | 2.40% | $33.74M | 0.61% | May 29, 2026 |
| Vanguard Small-Cap Index Fund | 1,102,113 | 2.17% | $30.84M | 0.02% | Jun 30, 2026 |
| Ab Discovery Growth Fund, Inc. | 737,624 | 1.45% | $20.64M | 0.71% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 632,851 | 1.24% | $17.71M | 0.04% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 580,489 | 1.14% | $16.24M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 545,392 | 1.07% | $20.59M | 0.06% | Jul 31, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 461,390 | 0.91% | $12.91M | 0.22% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 460,871 | 0.91% | $12.90M | 0.08% | Jun 30, 2026 |
| Champlain Small Company Fund | 383,000 | 0.75% | $10.72M | 1.29% | Jun 30, 2026 |
| Osterweis Opportunity Fund | 353,985 | 0.70% | $9.90M | 2.59% | Jun 30, 2026 |
| MFS New Discovery Fund | 341,866 | 0.67% | $9.46M | 0.44% | May 31, 2026 |
| EQ/AB Small Cap Growth Portfolio | 305,345 | 0.60% | $8.54M | 0.38% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael H. Carrel | President, CEO, & Director | 796,694 | 1.57% | Aug 3, 2026 |
| Salvatore Privitera | Chief Technical Officer | 134,341 | 0.26% | Nov 5, 2026 |
| Karl S. Dahlquist | Chief Legal Officer | 87,319 | 0.17% | Aug 26, 2026 |
| Justin J. Noznesky | Chief Mktg & Strategy Officer | 100,219 | 0.20% | Jul 30, 2026 |
| Vinayak Doraiswamy | Chief Scientific Officer | 86,511 | 0.17% | Jul 30, 2026 |
| Douglas J. Seith | Chief Operating Officer | 229,867 | 0.45% | Jul 2, 2026 |
| Angela L. Wirick | Chief Financial Officer | 204,893 | 0.40% | Mar 3, 2026 |
| Deborah Lee Yount | Chief Human Resources Officer | 57,539 | 0.11% | Mar 4, 2025 |
| B. Kristine Johnson | Director | 53,502 | 0.11% | Nov 10, 2026 |
| Regina E. Groves | Director | 34,546 | 0.07% | Sep 14, 2026 |
| Maggie Yuen | Director | 14,015 | 0.03% | Aug 7, 2026 |
| Karen Prange | Director | 22,809 | 0.04% | Aug 7, 2026 |
| Sven Wehrwein | Director | 40,518 | 0.08% | Jul 30, 2026 |
| Deborah H. Telman | Director | 28,328 | 0.06% | May 20, 2026 |
| Robert S. White | Director | 128,318 | 0.25% | May 20, 2026 |
| Shlomo Nachman | Director | 24,655 | 0.05% | May 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| B. Kristine Johnson Director | Nov 6, 2026 | Sale | −2,452 | $58.48 | $143.39K | 53,502 |
| Salvatore Privitera Chief Technical Officer | Nov 4, 2026 | Sale(10b5-1 plan) | −8,404 | $65.00 | $546.26K | 134,341 |
| Salvatore Privitera Chief Technical Officer | Sep 23, 2026 | Sale(10b5-1 plan) | −4,519 | $60.00 | $271.14K | 142,745 |
| Regina E. Groves Director | Sep 11, 2026 | Sale | −5,313 | $54.22 | $288.07K | 34,546 |
| Salvatore Privitera Chief Technical Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −3,657 | $55.00 | $201.14K | 147,264 |
| Salvatore Privitera Chief Technical Officer | Sep 2, 2026 | Sale(10b5-1 plan) | −7,763 | $52.50 | $407.56K | 150,921 |
| Karl S. Dahlquist Chief Legal Officer | Aug 24, 2026 | Sale | −9,370 | $48.89 | $458.10K | 87,319 |
| Maggie Yuen Director | Aug 5, 2026 | Sale | −3,500 | $38.42 | $134.47K | 14,015 |
| Karen Prange Director | Aug 5, 2026 | Sale | −3,564 | $38.80 | $138.28K | 22,809 |
| Michael H. Carrel President, CEO, & Director | Jul 30, 2026 | Gift | −700 | – | – | 778,434 |
| Michael H. Carrel President, CEO, & Director | Jul 30, 2026 | Gift | −4,000 | – | – | 774,434 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Jul 29, 2026 | Sale | −6,182 | $38.80 | $239.86K | 100,219 |
| Vinayak Doraiswamy Chief Scientific Officer | Jul 28, 2026 | Sale | −6,000 | $38.88 | $233.28K | 86,511 |
| Sven Wehrwein Director | Jul 28, 2026 | Sale | −25,000 | $37.84 | $946.00K | 40,518 |
| Sven Wehrwein Director | Jul 28, 2026 | Option exercise | +25,000 | $19.95 | $498.75K | 65,518 |
| Salvatore Privitera Chief Technical Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 158,684 |
| Douglas J. Seith Chief Operating Officer | Jun 30, 2026 | Award | +527 | $23.78 | $12.53K | 229,867 |
| Karl S. Dahlquist Chief Legal Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 96,689 |
| Vinayak Doraiswamy Chief Scientific Officer | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 92,511 |
| Michael H. Carrel President, CEO, & Director | Jun 30, 2026 | Award | +636 | $23.78 | $15.12K | 779,134 |
| Karen Prange Director | May 20, 2026 | Sale | −3,000 | $28.65 | $85.95K | 26,373 |
| Deborah H. Telman Director | May 18, 2026 | Award | +6,144 | – | – | 28,328 |
| Robert S. White Director | May 18, 2026 | Award | +6,144 | – | – | 128,318 |
| Karen Prange Director | May 18, 2026 | Award | +6,144 | – | – | 29,373 |
| Sven Wehrwein Director | May 18, 2026 | Award | +6,144 | – | – | 40,518 |
| Regina E. Groves Director | May 18, 2026 | Award | +6,144 | – | – | 39,859 |
| Maggie Yuen Director | May 18, 2026 | Award | +6,144 | – | – | 17,515 |
| B. Kristine Johnson Director | May 18, 2026 | Award | +6,144 | – | – | 55,954 |
| Shlomo Nachman Director | May 18, 2026 | Award | +6,144 | – | – | 24,655 |
| Vinayak Doraiswamy Chief Scientific Officer | May 15, 2026 | Sale | −5,000 | $28.13 | $140.65K | 91,875 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 12, 2026 | Sale | −5,000 | $29.83 | $149.15K | 96,875 |
| Robert S. White Director | Mar 10, 2026 | Option exercise | +10,000 | $14.99 | $149.90K | 122,174 |
| Michael H. Carrel President, CEO, & Director | Mar 6, 2026 | Gift | −1,000 | – | – | 778,498 |
| Michael H. Carrel President, CEO, & Director | Mar 6, 2026 | Gift | −5,000 | – | – | 779,498 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Tax withholding | −15,586 | $31.26 | $487.22K | 106,401 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Award | +27,991 | – | – | 106,789 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Mar 1, 2026 | Award | +15,198 | – | – | 121,987 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Tax withholding | −22,965 | $31.26 | $717.89K | 204,893 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Award | +23,101 | – | – | 227,858 |
| Angela L. Wirick Chief Financial Officer | Mar 1, 2026 | Award | +39,987 | – | – | 204,757 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Tax withholding | −22,948 | $31.26 | $717.35K | 229,340 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Award | +42,386 | – | – | 226,756 |
| Douglas J. Seith Chief Operating Officer | Mar 1, 2026 | Award | +25,532 | – | – | 252,288 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Award | +27,991 | – | – | 96,542 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Tax withholding | −15,687 | $31.26 | $490.38K | 96,053 |
| Karl S. Dahlquist Chief Legal Officer | Mar 1, 2026 | Award | +15,198 | – | – | 111,740 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −15,585 | $31.26 | $487.19K | 101,875 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Award | +15,198 | – | – | 117,460 |
| Vinayak Doraiswamy Chief Scientific Officer | Mar 1, 2026 | Award | +30,390 | – | – | 102,262 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Tax withholding | −72,777 | $31.26 | $2.28M | 784,498 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Award | +101,280 | – | – | 857,275 |
| Michael H. Carrel President, CEO, & Director | Mar 1, 2026 | Award | +68,618 | – | – | 755,995 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Award | +30,390 | – | – | 155,977 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Award | +15,198 | – | – | 171,175 |
| Salvatore Privitera Chief Technical Officer | Mar 1, 2026 | Tax withholding | −13,127 | $31.26 | $410.35K | 158,048 |
| Douglas J. Seith Chief Operating Officer | Dec 31, 2025 | Award | +257 | $27.37 | $7.03K | 184,370 |
| Michael H. Carrel President, CEO, & Director | Dec 10, 2025 | Gift | −4,000 | – | – | 687,377 |
| Justin J. Noznesky Chief Mktg & Strategy Officer | Nov 26, 2025 | Sale | −5,166 | $37.29 | $192.64K | 78,798 |
| Sven Wehrwein Director | Nov 25, 2025 | Sale | −4,967 | $38.00 | $188.75K | 34,374 |
| Sven Wehrwein Director | Nov 25, 2025 | Option exercise | +4,967 | $19.95 | $99.09K | 39,341 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AtriCure's stock actually held short. Settlement fails (shares not delivered on time) peaked at 63,982 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| B Kristine Johnson Declaration Trust Director | Nov 6, 2026 | 2,452 | $143.40K | Nov 6, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Salvatore Privitera Officer | Nov 4, 2026 | 8,404 | $546.26K | Nov 4, 2026 | Restricted Stock |
| Salvatore Privitera Officer | Sep 23, 2026 | 4,519 | $271.14K | Sep 23, 2026 | Performance Shares |
| Regina E. Groves Director | Sep 11, 2026 | 5,313 | $285.10K | Sep 10, 2026 | Stock Award |
| Salvatore Privitera Officer | Sep 8, 2026 | 3,657 | $201.14K | Sep 8, 2026 | Performance Shares |
| Salvatore Privitera Officer | Sep 2, 2026 | 7,763 | $407.56K | Sep 2, 2026 | Restricted Stock |
| Karl S. Dahlquist Officer | Aug 24, 2026 | 9,370 | $458.09K | Aug 24, 2026 | Performance Shares |
| Maggie Yuen Director | Aug 5, 2026 | 3,500 | $134.47K | Aug 5, 2026 | Restricted Stock |
| Karen Prange Director | Aug 5, 2026 | 3,564 | $139.00K | Aug 5, 2026 | Stock Award |
| Justin J. Noznesky Officer | Jul 29, 2026 | 6,182 | $239.88K | Jul 29, 2026 | STOCK GRANT |
| Sven Wehrwein Director | Jul 28, 2026 | 25,000 | $964.44K | Jul 28, 2026 | Stock Option Exercise |
| Vinayak Doraiswamy Officer | Jul 28, 2026 | 6,000 | $233.28K | Jul 28, 2026 | Performance Shares |
| Karen Prange Director | May 20, 2026 | 3,000 | $86.40K | May 20, 2026 | Stock Award |
| Vinayak Doraiswamy Officer | May 15, 2026 | 5,000 | $140.67K | May 15, 2026 | Performance Shares |
| Vinayak Doraiswamy Officer | Mar 12, 2026 | 5,000 | $149.15K | Mar 12, 2026 | Performance Shares |
Congress trades
13 trades in AtriCure reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Sold (part) | Sep 29, 2026 | $1K–15K | Oct 12, 2026 |
| Gilbert Cisneros CA31 | Bought | Aug 20, 2026 | $1K–15K | Sep 10, 2026 |
| Gilbert Cisneros CA31 | Bought | Mar 3, 2026 | $1K–15K | Apr 7, 2026 |
| Gilbert Cisneros CA31 | Bought | May 6, 2025 | $1K–15K | Jun 6, 2025 |
| Josh Gottheimer NJ05 · joint account | Bought | Jul 19, 2024 | $1K–15K | Aug 15, 2024 |
| Josh Gottheimer NJ05 · joint account | Sold | Jun 18, 2024 | $1K–15K | Jul 9, 2024 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jun 8, 2021 | $1K–15K | Jul 15, 2021 |
| Gilbert Cisneros CA31 | Sold (part) | Apr 30, 2020 | $1K–15K | May 13, 2020 |
| Gilbert Cisneros CA31 | Bought | Mar 31, 2020 | $1K–15K | Apr 16, 2020 |
| Gilbert Cisneros CA31 | Sold (part) | Feb 21, 2020 | $1K–15K | Mar 10, 2020 |
| Gilbert Cisneros CA31 | Bought | Nov 7, 2019 | $1K–15K | Dec 11, 2019 |
| Gilbert Cisneros CA31 | Bought | Jun 27, 2019 | $1K–15K | Jul 12, 2019 |
| Gilbert Cisneros CA31 | Bought | May 8, 2019 | $1K–15K | Jun 18, 2019 |
See a number that looks wrong?